AstraZeneca has received a green signal from the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) for a protocol being amended to widen the ongoing global clinical trial
Roche Pharma India today announced the successful completion of the first phase of its Advanced Inclusive Research (AIR) Site Alliance initiative in India, having partnered with 10 leading government hospitals from across the country and trained...
The Bombay High Court has given an interim injunction to Sun Pharma Laboratories Limited, which will stop Rambo Lifesciences Pvt. Ltd.
The Association of Indian Medical Device Industry (AiMeD) has expressed its whole-hearted support for the latest instructions issued by the Department of Pharmaceuticals (DoP), National Pharmaceutical Pricing Authority
The healthcare chain Apollo Hospitals Entreprise Ltd said that it will pay Rs 1,254.07 crore to purchase the 31% share that International Finance Corporation had in its subsidiary Apollo Health and Lifestyle Ltd.
The new GST regime, the government has instructed pharmaceutical companies to rework the maximum retail price (MRP) of drugs, formulations, and medical devices from September 22, 2025.
Cotec Healthcare, one of the most successful contract development and manufacturing organizations (CDMO), in India has petitioned its Draft Red Herring Prospectus with an intention to raise up to 750 crores of funds by way of Fresh Issue plus an...
Natco Pharma Limited, a wholly owned subsidiary in South Africa, conjointly with Adcock Ingram Holdings Limited, has circulated a joint circular to the Adcock Ingram’s shareholders.
Merck (known as MSD outside of the US and Canada) presented positive Phase 3 trial results for Capvaxive for kids at the 6th ESCMID Conference on Vaccines in Lisbon, Portugal. The STRIDE-13 study assessed the vaccine in children and adolescents...
The U.S. Food and Drug Administration (FDA), with the support of the Department of Health and Human Services (HHS), has revealed strict measures, With the aim to shield consumers in a major way